Analyses of human gliomas by restriction landmark genomic scanning.
The 16 primary gliomas were examined for changes in genomic DNA using a recently developed 2-dimensional gel electrophoresis method called restriction landmark genomic scanning (RLGS). This approach allows detection of DNA amplification, deletion, methylation and potentially other genetic rearrangements represented as decreases and increases in spot/fragment intensity on an autoradiogram. Approximately 2,000 landmark sites in tumor DNA were compared with those of DNA isolated from normal brain tissues. Seven spots showing intensified signal were consistently detected in at least 50% of tumors, implying activation of corresponding DNA sequences, and 8 additional spots having reduced signal were observed, again in more than 50% of all tumors, suggesting inactivation by the loss of 1 allele or homozygous deletion. Decreased signal may also infer relative CpG island methylation state. Of those spots consistently identified in tumors, 2 amplified and 4 reduced spots were found to be characteristic of low- and high-grade tumors, while the remaining 5 amplified and 4 reduced spots were associated with high-grade gliomas only, suggesting a link of specific mutations to degree of malignancy. A separate subset of glioblastomas evaluated, however, showed no alterations in these 'hot spots' which were detected in even low grade astrocytomas. The results demonstrate the genetic heterogeneity of glioblastoma and implicate the progression of neoplasia via differing genetic pathways.
Nakamura
M
M
Department of Neurosurgery, Nara Medical University, Kashihara, Japan.
Konishi
N
N
Tsunoda
S
S
Hiasa
Y
Y
Tsuzuki
T
T
Aoki
H
H
Kobitsu
K
K
Nagai
H
H
Sakaki
T
T
D001254:Astrocytoma / Q000235:genetics*; D019175:DNA Methylation; D015180:Electrophoresis, Gel, Two-Dimensional; D015894:Genome, Human; D005909:Glioblastoma / Q000235:genetics*; D006801:Humans; D012189:Retrospective Studies